SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 21st, 2024 • Invizyne Technologies Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledOctober 21st, 2024 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (the “Agreement”) is dated as of the ___ day of __________ 2024, by and among INVIZYNE Technologies Inc., a Nevada corporation (the “Company”) and [________] each individual or entity named on the Schedule of Buyers attached hereto (each such individual or entity, individually, a “Buyer” and all of such individuals or entities, collectively, the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 8th, 2021 • theMaven, Inc. • Cable & other pay television services • New York
Contract Type FiledJanuary 8th, 2021 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (the “Agreement”) is dated as of the 30th day of March 2018, by and among TheMaven, Inc., a Delaware corporation (the “Company”) and each individual or entity named on the Schedule of Buyers attached hereto (each such individual or entity, individually, a “Buyer” and all of such individuals or entities, collectively, the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 16th, 2020 • Hancock Jaffe Laboratories, Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledJuly 16th, 2020 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (the “Agreement”) is dated as of the [___] day of July, 2020, by and between Hancock Jaffe Laboratories, Inc., a Delaware corporation (the Company”), and each individual or entity named on the Schedule of Buyers attached hereto (each such individual or entity, individually, a “Buyer” and all of such individuals or entities, collectively, the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 2nd, 2020 • Hancock Jaffe Laboratories, Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledMarch 2nd, 2020 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (the “Agreement”) is dated as of the 25th day of February 2020, by and between Hancock Jaffe Laboratories, Inc., a Delaware corporation (the Company”), and each individual or entity named on the Schedule of Buyers attached hereto (each such individual or entity, individually, a “Buyer” and all of such individuals or entities, collectively, the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 26th, 2019 • ENDRA Life Sciences Inc. • Electromedical & electrotherapeutic apparatus • New York
Contract Type FiledDecember 26th, 2019 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (the “Agreement”) is dated as of the 19th day of December 2019, by and between ENDRA Life Sciences Inc., a Delaware corporation (the “Company”), and each individual or entity named on the Schedule of Buyers attached hereto (each such individual or entity, individually, a “Buyer” and all of such individuals or entities, collectively, the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 11th, 2019 • ENDRA Life Sciences Inc. • Electromedical & electrotherapeutic apparatus • New York
Contract Type FiledDecember 11th, 2019 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (the “Agreement”) is dated as of the 5th day of December 2019, by and between ENDRA Life Sciences Inc., a Delaware corporation (the “Company”), and each individual or entity named on the Schedule of Buyers attached hereto (each such individual or entity, individually, a “Buyer” and all of such individuals or entities, collectively, the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 6th, 2019 • Resonant Inc • Semiconductors & related devices • California
Contract Type FiledAugust 6th, 2019 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (the “Agreement”) is dated as of July 31, 2019, by and between Resonant Inc., a Delaware corporation (the “Company”), and each individual or entity named on the Schedule of Buyers attached hereto (each such individual or entity, individually, a “Buyer” and all of such individuals or entities, collectively, the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 29th, 2019 • ENDRA Life Sciences Inc. • Electromedical & electrotherapeutic apparatus • New York
Contract Type FiledJuly 29th, 2019 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (the “Agreement”) is dated as of the 26th day of July 2019, by and between ENDRA Life Sciences Inc., a Delaware corporation (the “Company”), and each individual or entity named on the Schedule of Buyers attached hereto (each such individual or entity, individually, a “Buyer” and all of such individuals or entities, collectively, the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 5th, 2018 • Mobivity Holdings Corp. • Services-prepackaged software • New York
Contract Type FiledJuly 5th, 2018 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (the “Agreement”) is dated as of the 28th day of June 2018 by and between MOBIVITY HOLDINGS CORP., a Nevada corporation (the “Company”), and each individual or entity named on the Schedule of Buyers attached hereto (each such individual or entity, individually, a “Buyer” and all of such individuals or entities, collectively, the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 2nd, 2018 • ENDRA Life Sciences Inc. • Electromedical & electrotherapeutic apparatus • New York
Contract Type FiledJuly 2nd, 2018 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (the “Agreement”) is dated as of the 28th day of June 2018, by and between ENDRA Life Sciences, Inc., a Delaware corporation (the “Company”), and each individual or entity named on the Schedule of Buyers attached hereto (each such individual or entity, individually, a “Buyer” and all of such individuals or entities, collectively, the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 5th, 2018 • theMaven, Inc. • Cable & other pay television services • New York
Contract Type FiledJanuary 5th, 2018 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (the “Agreement”) is dated as of the ____ day of _________ 2017, by and among theMaven, Inc., a Delaware corporation (the “Company”), MDB Capital Group, LLC, a Texas limited liability company (the “Placement Agent”), and each individual or entity named on the Schedule of Buyers attached hereto (each such individual or entity, individually, a “Buyer” and all of such individuals or entities, collectively, the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 19th, 2017 • theMaven, Inc. • Cable & other pay television services • New York
Contract Type FiledOctober 19th, 2017 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (the “Agreement”) is dated as of the 19th day of October 2017, by and among theMaven, Inc., a Delaware corporation (the “Company”), MDB Capital Group, LLC, a Texas limited liability company (the “Placement Agent”), and each individual or entity named on the Schedule of Buyers attached hereto (each such individual or entity, individually, a “Buyer” and all of such individuals or entities, collectively, the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 10th, 2017 • theMaven, Inc. • Cable & other pay television services • New York
Contract Type FiledApril 10th, 2017 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (the “Agreement”) is dated as of the 4th day of April 2017, by and among theMaven, Inc., a Delaware corporation (the “Company”), MDB Capital Group, LLC, a Texas limited liability company (the “Placement Agent”), and each individual or entity named on the Schedule of Buyers attached hereto (each such individual or entity, individually, a “Buyer” and all of such individuals or entities, collectively, the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 22nd, 2017 • Imprimis Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 22nd, 2017 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (the “Agreement”) is dated as of the 21st day of March 2017, by and between Imprimis Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each individual or entity named on the Schedule of Buyers attached hereto (each such individual or entity, individually, a “Buyer” and all of such individuals or entities, collectively, the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 24th, 2017 • Resonant Inc • Semiconductors & related devices • California
Contract Type FiledFebruary 24th, 2017 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (the “Agreement”) is dated as of February 20, 2017, by and between Resonant Inc., a Delaware corporation (the “Company”), and each individual or entity named on the Schedule of Buyers attached hereto (each such individual or entity, individually, a “Buyer” and all of such individuals or entities, collectively, the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 23rd, 2016 • Imprimis Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledDecember 23rd, 2016 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (the “Agreement”) is dated as of the 19th day of December 2016, by and between Imprimis Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each individual or entity named on the Schedule of Buyers attached hereto (each such individual or entity, individually, a “Buyer” and all of such individuals or entities, collectively, the “Buyers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 30th, 2016 • Mobivity Holdings Corp. • Services-prepackaged software • New York
Contract Type FiledMarch 30th, 2016 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (the “Agreement”) is dated as of the 7th day of March, 2016, by and between MOBIVITY HOLDINGS CORP., a Nevada corporation (the “Company”), and each individual or entity named on the Schedule of Buyers attached hereto (each such individual or entity, individually, a “Buyer” and all of such individuals or entities, collectively, the “Buyers”).